NIHR Maudsley BRC Blog

Our latest news & events

Making referrals to the AVATAR2 trial: An interview with Dr Helen Harding

The AVATAR2 trial is a multi-centre study of therapy aiming to help people who hear distressing voices by enabling them to build an avatar to represent the owner of the voice. Referrers play a pivotal role by recommending participants take part in the trial. Here Clinical Psychologist, Dr Helen Harding, talks about the referral process and how she sees the research benefitting patients in the short and long term. Dr Harding is a Clinical Psychologist in Lambeth Community Services.

By NIHR Maudsley BRC at 20 May 2022

VIEWER platform receives high commendation for Best Mental Health Partnership with the NHS at 2022 HSJ Partnership Awards

The Psychosis VIEWER population health management platform has received high commendation at the 2022 HSJ Partnership Awards.

By NIHR Maudsley BRC at 25 Mar 2022

Professor Ammar Al-Chalabi receives Forbes Norris Award

Professor Al-Chalabi received the award at the 31st International Symposium on ALS/MND on December 9 2020

 

By NIHR Maudsley BRC at 11 Dec 2020

Thirty risk factors found during and after pregnancy for children developing psychosis

More than 30 significant risk factors have been identified for the development of psychotic disorders in offspring in research led by the NIHR Maudsley BRC. It is the first comprehensive meta-analysis of pre- and perinatal risk factors for psychosis in nearly 20 years.

By NIHR Maudsley BRC at 24 Mar 2020

Could intranasal oxytocin be used to treat people at clinically high risk of psychosis?

Oxytocin, a hormone most often associated with childbirth, is also known for its effects on social-emotional cognition and behaviour. According to new research supported by the NIHR Maudsley BRC, oxytocin also alters blood flow in the hippocampus — a brain region strongly implicated in the onset of psychosis — in those at clinically high risk of psychosis.

By NIHR Maudsley BRC at 12 Feb 2019